ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 78 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,770 | -20.4% | 265 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $2,223 | -15.5% | 265 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,631 | -59.3% | 265 | -71.5% | 0.00% | -75.0% |
| Q4 2022 | $6,466 | +29.3% | 929 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $5,000 | +25.0% | 929 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $4,000 | +100.0% | 929 | +121.7% | 0.00% | +100.0% |
| Q4 2021 | $2,000 | -50.0% | 419 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $4,000 | -20.0% | 419 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $5,000 | 0.0% | 419 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | +66.7% | 419 | -21.4% | 0.00% | +50.0% |
| Q4 2020 | $3,000 | +50.0% | 533 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | -60.0% | 533 | -43.1% | 0.00% | -33.3% |
| Q3 2019 | $5,000 | -16.7% | 936 | -5.5% | 0.00% | -25.0% |
| Q2 2019 | $6,000 | -33.3% | 990 | 0.0% | 0.00% | -42.9% |
| Q1 2019 | $9,000 | -40.0% | 990 | -7.0% | 0.01% | 0.0% |
| Q3 2018 | $15,000 | – | 1,065 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 473,446 | $5,625,000 | 4.61% |
| Knoll Capital Management, LLC | 569,405 | $6,765,000 | 4.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 321,879 | $3,824,000 | 2.09% |
| First Light Asset Management, LLC | 2,624,001 | $31,173,000 | 2.07% |
| Mesirow Financial Investment Management, Inc. | 63,634 | $756,000 | 2.06% |
| Ghost Tree Capital, LLC | 650,000 | $7,722,000 | 1.82% |
| Altium Capital Management LP | 548,225 | $6,513,000 | 1.81% |
| Perceptive Advisors | 8,703,879 | $103,402,000 | 1.31% |
| Affinity Asset Advisors, LLC | 300,000 | $3,564,000 | 1.21% |
| Avidity Partners Management LP | 2,552,000 | $30,318,000 | 0.84% |